Cargando…
Au-siRNA@ aptamer nanocages as a high-efficiency drug and gene delivery system for targeted lung cancer therapy
BACKGROUND: Gene and chemical therapy has become one of the rising stars in the field of molecular medicine during the last two decades. However, there are still numerous challenges in the development of efficient, targeted, and safe delivery systems that can avoid siRNA degradation and reduce the t...
Autores principales: | Yang, Yuming, Han, Yu, Sun, Qiuyang, Cheng, Jin, Yue, Caixia, Liu, Yanlei, Song, Jie, Jin, Weilin, Ding, Xianting, de la Fuente, Jesús M., Ni, Jian, Wang, Xiaoqiang, Cui, Daxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905599/ https://www.ncbi.nlm.nih.gov/pubmed/33627152 http://dx.doi.org/10.1186/s12951-020-00759-3 |
Ejemplares similares
-
Dual-targeted lung cancer therapy via inhalation delivery of UCNP-siRNA-AS1411 nanocages
por: Han, Yu, et al.
Publicado: (2022) -
Aptamer mediated siRNA delivery
por: Chu, Ted C., et al.
Publicado: (2006) -
Engineering a Novel
Self-Assembled Multi-siRNA Nanocaged
Architecture with Controlled Enzyme-Mediated siRNA Release
por: Moreno, Pedro M. D., et al.
Publicado: (2022) -
A Universal Protein Tag for Delivery of SiRNA-Aptamer Chimeras
por: Liu, Hong Yan, et al.
Publicado: (2013) -
Aptamers as Delivery Agents of siRNA and Chimeric Formulations for the Treatment of Cancer
por: Dinis Ano Bom, Ana Paula, et al.
Publicado: (2019)